Abstract

The parasite protozoan Leishmania, the causative agent of leishmaniasis, includes two subgenera of medical interest: Leishmania (Leishmania) and Leishmania (Viannia). Parasite species detection and characterization is crucial to choose treatment protocols and to monitor the disease evolution. Molecular approaches can speed up and simplify the diagnostic process. In particular, several molecular assays target the mitochondrial DNA minicircle network (kDNA) that characterizes the Leishmania genus. We previously proposed a qPCR assay targeting kDNA, followed by high resolution melt (HRM) analysis (qPCR-ML) to distinguish L. (L.) infantum and L. (L.) amazonensis from L. Viannia species. Successively, this assay has been integrated with other qPCR assays, to differentiate L. (L.) infantum, L. (L.) amazonensis and L. (L.) mexicana. In this work, we tested the applicability of our qPCR-ML assay on L. (L.) donovani, L. (L.) major, L. (L.) tropica and L. (L.) aethiopica, showing that the qPCR-ML assay can also amplify Old World species, different from L. (L.) infantum, with good quantification limits (1 × 10−4–1 × 10−6 ng/pcr tube). Moreover, we evaluated 11 L. (L.) infantum strains/isolates, evidencing the variability of the kDNA minicircle target molecules among the strains/isolates of the same species, and pointing out the possibility of quantification using different strains as reference. Taken together, these data account for the consideration of qPCR-ML as a quantitative pan-Leishmania assay.

Highlights

  • Leishmania spp. is a protozoan parasite widespread in Asia, Africa, Europe and America

  • The subgenus Leishmania (Leishmania) includes species responsible for visceral leishmaniasis (VL) [L. (L.) donovani, L. (L.) infantum] and cutaneous leishmaniasis (CL) [L. (L.) infantum, L. (L.) major, L. (L.) tropica, L. (L.) aethiopica, L. (L.) mexicana, L. (L.) amazonensis], while the species belonging to the subgenus Leishmania (Viannia) are the etiological agents of CL and mucocutaneous leishmaniasis (MCL) [2]

  • We previously showed that qPCR-ML was able to detect Old World L. (L.) infantum and New world species [i.e., L. (L.) chagasi/infantum, L. (L.) amazonensis, L. (L.) mexicana, L. (V.) guyanensis, L. (V.) panamensis, L. (V.) braziliensis] and among these species, distinguishing between Leishmania and Viannia subgenera [6,8]

Read more

Summary

Introduction

Leishmania spp. is a protozoan parasite widespread in Asia, Africa, Europe and America. (L.) amazonensis], while the species belonging to the subgenus Leishmania (Viannia) are the etiological agents of CL and mucocutaneous leishmaniasis (MCL) [2]. A number of PCR-based assays are targeting the mitochondrial DNA minicircle network (kDNA) that characterizes the Leishmania genus, ensuring very high sensitivity [5]. This assay has been integrated with other qPCR assays to differentiate L. These approaches have been applied to Brazilian clinical samples, allowing to distinguish different species causing infection in the New World [9]. Considering the Old World Leishmania species, the qPCR-ML assay has been tested only on L. We tested the applicability of our qPCR-ML assay in Old World Leishmania species different from L. We quantitatively evaluated the target sequence of qPCR-ML in different L. (L.) infantum strains and isolates to investigate the possibility of quantification in clinical applications

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call